Secondary Endpoints in Vaccine Efficacy Trials: Not Just an Afterthought
View Presentation View Presentation
*Karen Goldenthal, Bethesda Biologics Consult 


The selection of secondary endpoints requires careful consideration and prioritization, especially with regard to their potential inclusion in a future package insert. Approaches to secondary endpoints for vaccine clinical trials, including examples, will be presented.